In the high-risk world of biotech investing, there are no guarantees of success. Still, sometimes investors can find places where the odds look reasonable enough to consider buying shares.
News & Analysis: Ligand Pharmaceuticals
LGND earnings call for the period ending June 30, 2019.
LGND earnings call for the period ending March 30, 2019.
Looking for potential winning biotech stocks? These five check off all the boxes for investors.
Investors are not impressed with the company's plan to finance an acquisition spree.
LGND earnings call for the period ending December 31, 2018.
When Citron speaks, investors listen -- but should they?
Find out why a medical device maker, a gene sequencer, and a drug licensing company have our team of healthcare experts feeling bullish.
LGND earnings call for the period ending September 30, 2018.
It's been a tough month for these top healthcare stocks, which means it's time to go shopping.